KAI1／CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese

0.05). Conclusion: The authors believe that decreased and negative KAI1/CD82 expression in late-stage CAP may be related to tumor pro-gression and metastasis, and appears to be a prognostic marker.